MedPath
NMPA Approval

Revefenacin Inhalation Solution

国药准字HJ20250070

June 10, 2025

Drug Information

瑞维那新吸入溶液

吸入制剂

3ml:175μg

化学药品

June 10, 2025

June 9, 2030

Company Information

Applicant Company

Newenham Court, Northern Cross, Dublin 17, Dublin IRELAND

Manufacturing Company

1 Technology Circle, Columbia, SC 29203 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞维那新吸入溶液 - NMPA 批准文号 | MedPath